Cefixime NEW
| Price | $45 | $65 | $94 |
| Package | 25mg | 50mg | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Cefixime | CAS No.: 79350-37-1 |
| Purity: 99.33% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Cefixime |
| Description | Cefixime (FR-17027) is a broad-spectrum, third-generation cephalosporin antibiotic derived semisynthetically from the marine fungus Cephalosporium acremonium with antibacterial activity. As does penicillin, the beta-lactam antibiotic cefixime inhibits bacterial cell wall synthesis by disrupting peptidoglycan synthesis, resulting in a reduction in bacterial cell wall stability and bacterial cell lysis. Stable in the presence of a variety of beta-lactamases, this agent is more active against gram-negative bacteria and less active against gram-positive bacteria compared to second-generation cephalosporins. |
| Cell Research | The morphological changes of serovar Typhimurium FP39 in THP-1 cells are studied by light microscopy and transmission electron microscopy. Infected THP-1 cells are treated for 4 h with 0.5 μg of cefixime/ml. (Only for Reference) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Saline : < 10 mg/mL (22.05 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. Ethanol : hardly dissolve 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (22.05 mM), Solution. H2O : Insoluble DMSO : 166.7 mg/mL (367.63 mM), Sonication is recommended. |
| Keywords | PBPs | Inhibitor | inhibit | FR17027 | FR 17027 | FK027 | FK 027 | CL284635 | CL 284635 | Cefixime | Bacterial | Antibiotic |
| Inhibitors Related | Neomycin sulfate | Adipic dihydrazide | Levulinic acid | D(+)-Raffinose pentahydrate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Doxycycline | Hyaluronic acid sodium (MW 20 kDa) | Dimethyl sulfoxide | Sodium diacetate | Sodium bicarbonate | BES |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Approved Drug Library | ReFRAME Related Library | Drug Repurposing Compound Library | Inhibitor Library | NO PAINS Compound Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Covalent Inhibitor Library | Anti-Infection Compound Library | NMPA-Approved Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $45.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $45.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2025-05-08 | ||
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | ||
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-22 | ||
| $150.00 |
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-12-05 | ||
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-21 | ||
| $100.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2024-08-13 | |
|
VIP5Y
|
Sinoway Industrial co., ltd.
|
2024-05-27 | ||
| $15.00 |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-22 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY